SEROQUEL is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Astrazeneca Pharmaceuticals Lp. The primary component is Quetiapine Fumarate.
Product ID | 0310-0278_0ea67c30-9548-480f-99de-7678dc88a648 |
NDC | 0310-0278 |
Product Type | Human Prescription Drug |
Proprietary Name | SEROQUEL |
Generic Name | Quetiapine Fumarate |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2006-02-13 |
Marketing Category | NDA / NDA |
Application Number | NDA020639 |
Labeler Name | AstraZeneca Pharmaceuticals LP |
Substance Name | QUETIAPINE FUMARATE |
Active Ingredient Strength | 50 mg/1 |
Pharm Classes | Atypical Antipsychotic [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2006-02-13 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA020639 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2006-02-13 |
Marketing End Date | 2015-09-07 |
Marketing Category | NDA |
Application Number | NDA020639 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2006-02-13 |
Marketing Category | NDA |
Application Number | NDA020639 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2006-02-13 |
Marketing End Date | 2015-11-30 |
Ingredient | Strength |
---|---|
QUETIAPINE FUMARATE | 50 mg/1 |
SPL SET ID: | 0584dda8-bc3c-48fe-1a90-79608f78e8a0 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
21695-119 | SEROQUEL | SEROQUEL |
21695-117 | SEROQUEL | SEROQUEL |
21695-118 | SEROQUEL | SEROQUEL |
21695-120 | SEROQUEL | SEROQUEL |
55289-447 | SEROQUEL | SEROQUEL |
55289-187 | SEROQUEL | SEROQUEL |
55289-872 | SEROQUEL | SEROQUEL |
0310-0274 | SEROQUEL | SEROQUEL |
0310-0278 | SEROQUEL | SEROQUEL |
0310-0271 | SEROQUEL | SEROQUEL |
0310-0272 | SEROQUEL | SEROQUEL |
0310-0279 | SEROQUEL | SEROQUEL |
0310-0275 | SEROQUEL | SEROQUEL |
63629-3378 | SEROQUEL | SEROQUEL |
63629-3291 | SEROQUEL | SEROQUEL |
63629-3380 | SEROQUEL | SEROQUEL |
63629-3319 | SEROQUEL | SEROQUEL |
67046-666 | SEROQUEL | SEROQUEL |
67046-662 | SEROQUEL | SEROQUEL |
67046-664 | SEROQUEL | SEROQUEL |
67046-661 | SEROQUEL | SEROQUEL |
67046-660 | SEROQUEL | SEROQUEL |
67046-663 | SEROQUEL | SEROQUEL |
70518-2166 | SEROQUEL | SEROQUEL |
70518-2424 | SEROQUEL | SEROQUEL |
0054-0220 | Quetiapine Fumarate | Quetiapine Fumarate |
0054-0221 | Quetiapine Fumarate | Quetiapine Fumarate |
0054-0222 | Quetiapine Fumarate | Quetiapine Fumarate |
0054-0223 | Quetiapine Fumarate | Quetiapine Fumarate |
0054-0229 | Quetiapine Fumarate | Quetiapine Fumarate |
0054-0230 | Quetiapine Fumarate | Quetiapine Fumarate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
SEROQUEL 73724400 1517746 Live/Registered |
IMPERIAL CHEMICAL INDUSTRIES PLC 1988-04-25 |